Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
p53 status
Description:
p53 status describes the functional or molecular state of the TP53 tumor-suppressor gene or its protein in cancer research.
Related topic:
Cancer-related Molecular Pathways (16%)
OpenAlex ID:
keywords/tp53-status
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
2005
·
Lance D. Miller
, Johanna Smeds
, et al.
·
Proceedings of the National Academy of Sciences
·
1,281
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
2002
·
Valentina Zuco
, Rosanna Supino
, et al.
·
Cancer Letters
·
542
Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations
2014
·
Annan Yang
, N.V. Rajeshkumar
, et al.
·
Cancer Discovery
·
494
An informatics approach identifying markers of chemosensitivity in human cancer cell lines.
2000
·
S A Amundson
, T G Myers
, et al.
·
PubMed
·
408
A Gene Expression Model of Intrinsic Tumor Radiosensitivity: Prediction of Response and Prognosis After Chemoradiation
2009
·
Steven A. Eschrich
, Jimmy Pramana
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
378
Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis.
1994
·
Q Zhan
, S Fan
, et al.
·
PubMed
·
374
CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability
2002
·
Nicholas Hawkins
, Mark Norrie
, et al.
·
Gastroenterology
·
365
PDF
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
2008
·
Roberto Pallini
, Lucia Ricci-Vitiani
, et al.
·
Clinical Cancer Research
·
364
Radiation Sensitivity, H2AX Phosphorylation, and Kinetics of Repair of DNA Strand Breaks in Irradiated Cervical Cancer Cell Lines
2004
·
Judit P. Banáth
, Susan H. MacPhail
, et al.
·
Cancer Research
·
350
Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action
2008
·
Junmei Hou
, Disong Wang
, et al.
·
Clinical Cancer Research
·
326
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
2001
·
C R Antonescu
, S J Tschernyavsky
, et al.
·
PubMed
·
325
Systems Biology Modeling of the Radiation Sensitivity Network: A Biomarker Discovery Platform
2009
·
Steven Eschrich
, Hongling Zhang
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
282
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan
2019
·
Claire Vennin
, Pauline Mélénec
, et al.
·
Nature Communications
·
277
PDF
5-year Followup of a Randomized Prospective Study Comparing Mitomycin C and Bacillus Calmette-guerin in Patients With Superficial Bladder Carcinoma
1999
·
PER-UNO MALMSTROM
, HANS WIJKSTROM
, et al.
·
The Journal of Urology
·
246
Selective Reporting Biases in Cancer Prognostic Factor Studies
2005
·
Panayiotis A. Kyzas
, Konstantinos T. Loizou
, et al.
·
JNCI Journal of the National Cancer Institute
·
233
Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status
2011
·
Walter M. Stadler
, Seth P. Lerner
, et al.
·
Journal of Clinical Oncology
·
227
PDF
Non–Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation
2006
·
Amit K. Das
, Mitsuo Sato
, et al.
·
Cancer Research
·
221
PDF
Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
2008
·
Shuji Ogino
, Gregory J. Kirkner
, et al.
·
Clinical Cancer Research
·
213
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
2014
·
H. Bonnefoi
, S. Litière
, et al.
·
Annals of Oncology
·
208
PDF
Arsenic trioxide–induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL
2003
·
Qun Liu
, Susan Hilsenbeck
, et al.
·
Blood
·
206
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines
2000
·
Carol A. Delaney
, Lan Z. Wang
, et al.
·
PubMed
·
201
Screening thep53 status of human cell lines using a yeast functional assay
1997
·
Li-Qun Jia
, Motonobu Osada
, et al.
·
Molecular Carcinogenesis
·
179
In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.
2000
·
K R Rogulski
, S O Freytag
, et al.
·
PubMed
·
178
Gene expression patterns associated with p53 status in breast cancer
2006
·
Melissa A Troester
, Jason I Herschkowitz
, et al.
·
BMC Cancer
·
177
PDF
Antitumor Activity of NVP-BKM120—A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells
2011
·
Dimpy Koul
, Jun Fu
, et al.
·
Clinical Cancer Research
·
175
Show more works
View as search
Works count:
1,518
Citation count:
34,740
Year
Topic
Type